Literature DB >> 8855505

Inferior vena caval thrombus associated with double neoplasms of the retroperitoneum and kidney: report of a case.

K Furugaki1, J Yoshida, K Chijiiwa, S Naito, R Tominaga, T Hayashi, K Goto, S Tamiya, M Torisu, M Tanaka.   

Abstract

We report herein the case of a patient we recently encountered who was found to have a giant retroperitoneal tumor coincident with tumor thrombus in the inferior vena cava (IVC). On the assumption that the origin was retroperitoneal, the two lesions were resected using an intracaval filter. However, histopathological examination of the specimens revealed neurilemoma for the retroperitoneal tumor and adenocarcinoma for the tumor thrombus. A right renal tumor was subsequently detected, which led to right nephrectomy being performed en bloc with part of the IVC using a venoarterial bypass. Microscopy revealed carcinoma of the Bellini duct, or collecting duct, which is an extremely rare tumor. Retrospectively, a lesion with soft tissue density was noted in the renal vein. Surgical management focused on the prevention of pulmonary embolism. We describe this case because of its extreme rarity and its significance from the viewpoint of diagnosis and therapeutic strategies.

Entities:  

Mesh:

Year:  1996        PMID: 8855505     DOI: 10.1007/bf00311677

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

Review 1.  Epidemiology of adenocarcinoma of the kidney.

Authors:  E L Wynder; K Mabuchi; W F Whitmore
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

2.  Surgery for renal cell carcinoma in the vena cava.

Authors:  V F Marshall; R G Middleton; G R Holswade; E I Goldsmith
Journal:  J Urol       Date:  1970-04       Impact factor: 7.450

3.  Current concepts in the epidemiology and etiology of primary renal cell carcinoma.

Authors:  A F Kantor
Journal:  J Urol       Date:  1977-04       Impact factor: 7.450

4.  Massive intraoperative pulmonary tumor embolus from renal cell carcinoma.

Authors:  B Milne; F W Cervenko; A Morales; T A Salerno
Journal:  Anesthesiology       Date:  1981-03       Impact factor: 7.892

5.  Clinicopathological conference. Abdominal pain, left retroperitoneal mass and right renal mass in a 62-year-old man.

Authors:  H B Maddux; Y Walzer; J M Holbert; W West; M S Soloway
Journal:  J Urol       Date:  1984-02       Impact factor: 7.450

6.  [Apparent spontaneous regression of an inoperable kidney cancer].

Authors:  P Brunner
Journal:  Fortschr Med       Date:  1983-07-14

Review 7.  Collecting duct carcinoma of the kidney: a case report and review of the literature.

Authors:  M D Carter; S Tha; M G McLoughlin; D A Owen
Journal:  J Urol       Date:  1992-04       Impact factor: 7.450

8.  Extension of renal cell carcinoma into the vena cava: clinical review and surgical approach.

Authors:  T R Pritchett; G Lieskovsky; D G Skinner
Journal:  J Urol       Date:  1986-03       Impact factor: 7.450

9.  Renal cancer invading the inferior vena cava: clinical review and anatomical approach.

Authors:  R V Clayman; R Gonzalez; E E Fraley
Journal:  J Urol       Date:  1980-02       Impact factor: 7.450

Review 10.  Perirenal liposarcoma containing extramedullary hematopoiesis associated with renal cell carcinoma.

Authors:  D J Lewis; J W Moul; S C Williams; I A Sesterhenn; E Colon
Journal:  Urology       Date:  1994-01       Impact factor: 2.649

View more
  2 in total

1.  Management of renal collecting duct carcinoma: a systematic review and the McMaster experience.

Authors:  S Dason; C Allard; A Sheridan-Jonah; J Gill; H Jamshaid; T Aziz; B Kajal; A Kapoor
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

Review 2.  Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease.

Authors:  Cristina Suarez; David Marmolejo; Augusto Valdivia; Rafael Morales-Barrera; Macarena Gonzalez; Joaquin Mateo; Maria Eugenia Semidey; David Lorente; Enrique Trilla; Joan Carles
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.